![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1489438
¹æ»ç¼±·® °ü¸® ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç°º°, ¸ð´Þ¸®Æ¼º°, µµÀÔ Çüź°, ¸ÅÃ⠸𵨺°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¼¼°è ºÐ¼®Radiation Dose Management Market Forecasts to 2030 - Global Analysis By Product, Modality, Mode of Deployment, Revenue Model, Application, End User and by Geography |
Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ¹æ»ç¼±·® °ü¸® ½ÃÀåÀº 2023³â¿¡ 2¾ï 7,775¸¸ ´Þ·¯¸¦ Â÷ÁöÇϸç, 2030³â¿¡´Â 8¾ï 2,367¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß CAGRÀº 16.8%ÀÔ´Ï´Ù.
º¸°ÇÀÇ·á, ƯÈ÷ ¹æ»ç¼±°ú Á¾¾çÇÐ °°Àº Àü¹® ºÐ¾ß¿¡¼´Â ¹æ»ç¼±·® °ü¸®°¡ Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù. ¹æ»ç¼± Ä¡·á³ª ¿µ»ó Áø´Ü½Ã ȯÀÚ°¡ ¹Þ´Â ¹æ»ç¼±·®À» ¸é¹ÐÈ÷ ¸ð´ÏÅ͸µÇÏ°í °ü¸®ÇØ¾ß ÇÕ´Ï´Ù. À̸¦ À§Çؼ´Â ȯÀÚÀÇ ¾ÈÀüÀ» À¯ÁöÇÏ¸é¼ ÃÖ»óÀÇ ÀÓ»ó °á°ú¸¦ ´Þ¼ºÇϱâ À§ÇÑ ±ÕÇüÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ±ÕÇüÀ» ÀÌ·ç±â À§Çؼ´Â ¼±·® ¸ð´ÏÅ͸µ ¼ÒÇÁÆ®¿þ¾î ¹× ¼±·® °¨¼Ò Àü·«°ú °°Àº ÷´Ü ±â¼úÀ» »ç¿ëÇÏ¿© ÀÇ·áÁøÀÌ È¯ÀÚÀÇ ¿¬·É, üÁß, ÀÇÇÐÀû ¹è°æ µî¿¡ µû¶ó ƯÁ¤ ȯÀÚÀÇ ¹æ»ç¼±·®À» ¸ÂÃãÈÇÒ ¼ö ÀÖµµ·Ï ÇØ¾ß ÇÕ´Ï´Ù.
¹Ì±¹¹æ»ç¼±ÇÐȸ(ACR)¿¡ µû¸£¸é ¹æ»ç¼±·® °ü¸®´Â ÀÇ·á ¿µ»ó Áø´ÜÀÇ ÃÖ¿ì¼± °úÁ¦À̸ç, Áø´Ü ¿µ»óÀÇ Ç°ÁúÀ» À¯ÁöÇÏ¸é¼ ºÒÇÊ¿äÇÑ ¹æ»ç¼± ÇÇÆøÀ» ÃÖ¼ÒÈÇϰí ȯÀÚ Ä¡·á¸¦ ÃÖÀûÈÇÏ´Â µ¥ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù.
¹æ»ç¼± ¾ÈÀü¿¡ ´ëÇÑ Áö½Ä Çâ»ó
¹æ»ç¼± ¾ÈÀü¿¡ ´ëÇÑ È¯ÀÚ¿Í ÀÇ·áÁøÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¹æ»ç¼±·® °ü¸® ¼Ö·ç¼ÇÀÌ Á¡Á¡ ´õ ³Î¸® º¸±ÞµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·áÁøµéÀº ƯÈ÷ ¹æ»ç¼± °ü·Ã ºÎÀÛ¿ëÀÇ À§ÇèÀÌ ³ôÀº ¼Ò¾Æ ¹× ÀÓ»êºÎ ȯÀÚÀÇ ¹æ»ç¼± ³ëÃâÀ» ÁÙÀÌ´Â °ÍÀÌ ¾ó¸¶³ª Áß¿äÇÑÁö ÀνÄÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ¹æ»ç¼±°ú °ü·ÃµÈ À§Çè¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ȯÀÚµéÀº ÀÇ·áÁø¿¡°Ô ¹æ»ç¼± ³ëÃâ¿¡ ´ëÇÑ Ã¥ÀÓ°ú Åõ¸í¼ºÀ» ¿ä±¸Çϰí ÀÖ½À´Ï´Ù.
µ¥ÀÌÅÍ º¸¾È ¹× ÇÁ¶óÀ̹ö½Ã ¹®Á¦
ȯÀÚÀÇ ¹æ»ç¼±·® µ¥ÀÌÅÍ´Â ±â¹Ð¼ºÀÌ ³ô±â ¶§¹®¿¡ ƯÈ÷ ÀǷẸÇè »óÈ£¿î¿ë¼º ¹× Ã¥ÀÓ¿¡ °üÇÑ ¹ý·ü(HIPAA)°ú °°Àº ¾ö°ÝÇÑ ±ÔÁ¦¸¦ °í·ÁÇÒ ¶§ ÇÁ¶óÀ̹ö½Ã ¹× º¸¾È¿¡ ´ëÇÑ ¿ì·Á¸¦ ºÒ·¯ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù. ¹æ»ç¼±·® °ü¸® ¼Ö·ç¼ÇÀ» »ç¿ëÇÒ ¶§ ÀÇ·á ±â°üÀº ȯÀÚ Á¤º¸¸¦ ¹«´Ü Á¢±Ù, µ¥ÀÌÅÍ À¯Ãâ, »çÀ̹ö À§ÇùÀ¸·ÎºÎÅÍ º¸È£ÇØ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ ¹æ»ç¼±·® ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ °ß°íÇÑ º¸¾È ÇÁ·¹ÀÓ¿öÅ©¿¡´Â ¾ÈÀüÇÑ µ¥ÀÌÅÍ ÀúÀå, ¾ÏÈ£È, ¾×¼¼½º Á¦¾î ¹× °¨»ç ÃßÀûÀÌ Æ÷ÇԵǾî¾ß ÇÕ´Ï´Ù.
½ÅÈï ±¹°¡ ½ÃÀå °³Ã´
ÀÇ·á¿ë ¿µ»ó ±â¼úÀÇ »ç¿ë Áõ°¡¿Í °³¹ßµµ»ó±¹¿¡¼ ¾çÁúÀÇ ÀÇ·á ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¹æ»ç¼±·® °ü¸® ºÐ¾ß´Â Å« ¼ºÀå ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. Àεµ, Áß±¹, ºê¶óÁú, ³²¾ÆÇÁ¸®Ä«°øÈ±¹Àº ÀÇ·á ÀÎÇÁ¶ó°¡ ºü¸£°Ô È®ÀåµÇ°í ÀÖ´Â ±¹°¡ Áß Çϳª·Î, ½Ã¼³ Çö´ëÈ¿Í Ã·´Ü ¿µ»ó Áø´Ü ±â¹ýÀ» µµÀÔÇÏ´Â µ¥ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ À̵é Áö¿ª¿¡¼´Â ȯÀÚ ¿¹Èĸ¦ °³¼±ÇÏ°í ±¹Á¦ ¹æ»ç¼± ¾ÈÀü Ç¥ÁØÀ» ÁؼöÇϱâ À§ÇØ ¹æ»ç¼±·® °ü¸® ¼Ö·ç¼ÇÀÌ Á¡Á¡ ´õ ¸¹ÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù.
±ÔÁ¦ ÁؼöÀÇ ¾î·Á¿ò
¹æ»ç¼±·® °ü¸® ¼Ö·ç¼Ç ÇÁ·Î¹ÙÀÌ´õµéÀº ÇコÄÉ¾î »ê¾÷ÀÇ ±ÔÁ¦¿Í ±âÁØÀÇ º¯È·Î ÀÎÇØ ½É°¢ÇÑ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖÀ¸¸ç, FDAÀÇ Ç°Áú ½Ã½ºÅÛ ±ÔÁ¤(QSR), À¯·´ÀÇ ÀÇ·á±â±â ±ÔÁ¤(MDR), ¹æ»ç¼± ¾ÈÀü¿¡ °üÇÑ ¼ö¸¹Àº ±¹Á¦ Ç¥ÁØ µî ±ÔÁ¦¸¦ ÁؼöÇϱâ À§ÇØ Á¦Ç° °³¹ß, Å×½ºÆ®, ¹®¼È¿¡ Áö¼ÓÀûÀ¸·Î ÅõÀÚÇØ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©ÀÇ º¯È ¹× »õ·Î¿î Àǹ«»çÇ×ÀÇ µµÀÔÀ¸·Î ÀÎÇØ ±âÁ¸ ¹æ»ç¼±·® °ü¸® ¼Ö·ç¼ÇÀÇ ¾÷µ¥ÀÌÆ®°¡ ÇÊ¿äÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌ·Î ÀÎÇØ µµÀÔ ±â°£ÀÌ ±æ¾îÁö°í ºñ¿ëÀÌ »ó½ÂÇÒ ¼ö ÀÖ½À´Ï´Ù.
¹æ»ç¼±·® °ü¸®´Â COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ Å« ¿µÇâÀ» ¹Þ¾ÒÀ¸¸ç, ÀÌ´Â ±âȸ¿Í µµÀüÀ» µ¿½Ã¿¡ °¡Á®¿Ô½À´Ï´Ù. COVID-19 ÆÒµ¥¹Í Ãʱ⿡´Â ¿µ»ó Áø´Ü °Ë»ç ¹× ¼±ÅÃÀû ¼ö¼úÀÇ ¼ö°¡ °¨¼ÒÇÏ´Â µî ÀÇ·á ¼ºñ½º¿¡ È¥¶õÀÌ ¹ß»ýÇßÁö¸¸, ÀÌÈÄ °¨¿° ¿¹¹æ ¹× ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ¹æ»ç¼±·® ÃÖÀûÈÀÇ Á߿伺ÀÌ ºÎ°¢µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ Ä¡·á È¿°ú¿Í Áø´Ü Á¤È®µµ¸¦ Èñ»ýÇÏÁö ¾Ê°í ȯÀÚÀÇ ¹æ»ç¼± ÇÇÆøÀ» ÁÙÀ̱â À§ÇØ ¼±·® °ü¸® ¼Ö·ç¼ÇÀº ÀÇ·á ½Ã¼³¿¡¼ ÃÖ¿ì¼± °úÁ¦·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù.
¿¹Ãø±â°£ Áß CT(ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ) ºÐ¾ß°¡ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¹æ»ç¼±·® °ü¸® ½ÃÀåÀº ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT) ºÎ¹®ÀÌ ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ä¡·á Áöħ, ¼ö¼ú °èȹ, Áø´Ü µî ´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡¼ CT ¿µ»óÀÌ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµÊ¿¡ µû¶ó ¹æ»ç¼±·® °ü¸® ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ CT °Ë»ç´Â ´Ù¸¥ ¿µ»ó Áø´Ü ¹æ¹ýº¸´Ù ³ôÀº ¼±·®À» ÇÊ¿ä·Î Çϱ⠶§¹®¿¡ ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ¼±·® ÃÖÀûȸ¦ ¿ì¼±¼øÀ§¿¡ µÎ¾î¾ß ÇÕ´Ï´Ù. ±× °á°ú, CT ¿µ»ó¿ëÀ¸·Î Ưº°È÷ ¼³°èµÈ ¹æ»ç¼±·® °ü¸® Àü·«ÀÇ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµÇ´Â Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®
¹æ»ç¼±·® °ü¸® ½ÃÀå¿¡¼ Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®Àº ÀϹÝÀûÀ¸·Î °¡Àå ³ôÀº CAGRÀ» º¸À̰í ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¹æ»ç¼±·® °ü¸® ¼Ö·ç¼ÇÀÇ È®À强, À¯¿¬¼º ¹× Á¢±Ù¼ºÀ» ÅëÇØ ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â Ŭ¶ó¿ìµå¿¡¼ ¹æ»ç¼±·® µ¥ÀÌÅ͸¦ ¾ÈÀüÇÏ°Ô ÀúÀå, ó¸® ¹× Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½Ç½Ã°£À¸·Î µ¥ÀÌÅ͸¦ ¸ð´ÏÅ͸µÇϰí, ¼±·® ºÐ¼®¿¡ ´ëÇÑ ¿ø°Ý ¾×¼¼½º¸¦ Á¦°øÇϸç, ÇöÀç ÀÇ·á IT ÀÎÇÁ¶ó¿Í ¿øÈ°ÇÏ°Ô ÅëÇÕÇÒ ¼ö ÀÖ´Â ÀÌ ¼Ö·ç¼ÇÀÇ ´É·ÂÀº È¿À²¼º°ú ºñ¿ë È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ Å¬¶ó¿ìµå ±â¹Ý ¹æ»ç¼±·® °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â ÇコÄÉ¾î ºÐ¾ß¿¡¼ Ŭ¶ó¿ìµå ±â¹Ý ±â¼úÀÇ »ç¿ë È®´ë, µ¥ÀÌÅÍ »óÈ£¿î¿ë¼º ¹× ºÐ¼®¿¡ ±â¹ÝÇÑ ÀÇ»ç°áÁ¤¿¡ ´ëÇÑ Á߿伺 Áõ°¡·Î ÀÎÇØ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
¹æ»ç¼±·® °ü¸® ½ÃÀå¿¡¼´Â ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ¿ìÀ§¿¡´Â źźÇÑ ÀÇ·á ÀÎÇÁ¶ó, ÷´Ü ÀÇ·á ¿µ»ó ±â¼úÀÇ ³ôÀº µµÀÔ·ü, ¹æ»ç¼± ¾ÈÀüÀ» ¿ì¼±½ÃÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦, ÀÇ·á IT ¼Ö·ç¼Ç¿¡ ´ëÇÑ ´ë±Ô¸ð ÅõÀÚ µî ¿©·¯ ¿äÀÎÀÌ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºÏ¹Ì¿¡¼´Â ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀÇ Àû±ØÀûÀÎ ±â¼ú µµÀÔ°ú ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ °ü½ÉÀÌ ¼±·® °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
ÀϹÝÀûÀ¸·Î ¹æ»ç¼±·® °ü¸® ½ÃÀåÀÇ CAGRÀÌ °¡Àå ³ôÀº Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾çÀÔ´Ï´Ù. ÀÇ·áºñ ÁöÃâ Áõ°¡, ÷´Ü ÀÇ·á ¿µ»ó ±â¼úÀÇ ºü¸¥ µµÀÔ, ¹æ»ç¼± ¾ÈÀü¿¡ ´ëÇÑ °ü½É Áõ°¡, Áß±¹, Àεµ, ÀϺ», Çѱ¹ µîÀÇ ±¹°¡¿¡¼ È®´ëµÇ°í ÀÖ´Â ÀÇ·á ÀÎÇÁ¶ó°¡ ÀÌ Áö¿ªÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ½Ã½ºÅÛ Çö´ëÈ, ¾çÁúÀÇ ÀÇ·á ¼ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼º Çâ»ó, ȯÀÚ ¾ÈÀüÀ» º¸ÀåÇϱâ À§ÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ±¸Ãà°ú °°Àº Á¤ºÎÀÇ ±¸»óµµ ÀÌ ºÐ¾ßÀÇ ¹æ»ç¼±·® °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Radiation Dose Management Market is accounted for $277.75 million in 2023 and is expected to reach $823.67 million by 2030 growing at a CAGR of 16.8% during the forecast period. A vital component of healthcare, especially in specialties like radiology and oncology, is managing radiation doses. It entails closely monitoring and controlling the radiation dosage that a patient receives during radiation therapy or diagnostic imaging procedures. Achieving the best possible clinical results while maintaining patient safety must be balanced in order to accomplish this. Moreover, achieving this balance requires the use of advanced technologies, such as dose monitoring software and dose reduction strategies, which enable medical professionals to customize radiation doses for specific patients based on their age, weight, and medical background.
According to the American College of Radiology (ACR), radiation dose management is a top priority in medical imaging, with a focus on optimizing patient care by minimizing unnecessary radiation exposure while maintaining diagnostic image quality.
Raising knowledge about radiation safety
Radiation dose management solutions are becoming more and more popular as patients and healthcare professionals become more conscious of radiation safety. Healthcare practitioners are becoming more and more aware of how critical it is to reduce patients' exposure to radiation, especially in pediatric and pregnant populations where there is a higher risk of radiation-related side effects. Additionally, patients are also demanding greater accountability and transparency from healthcare providers regarding their radiation exposure as they become more aware of the risks associated with medical radiation.
Data security and privacy issues
Patient radiation dose data is sensitive, which raises privacy and security concerns, especially in light of strict regulations like the Health Insurance Portability and Accountability Act (HIPAA). While using radiation dose management solutions, healthcare organizations must protect patient information from unauthorized access, data breaches, and cyber threats. Furthermore, a strong security framework for radiation dose monitoring systems must include secure data storage, encryption, access controls, and audit trails.
Growth of the markets in developing countries
Radiation dose management has a lot of room to grow given the rising use of medical imaging technologies and the rising need for high-quality healthcare services in developing nations. India, China, Brazil, and South Africa are among the nations with rapidly expanding healthcare infrastructures that are investing in modernizing their facilities and introducing cutting-edge imaging modalities. Moreover, radiation dose management solutions are becoming more and more necessary as these areas work to enhance patient outcomes and adhere to international radiation safety standards.
Regulatory compliance difficulties
Radiation dose management solution providers face serious challenges from the healthcare industry's changing regulations and standards. Product development, testing, and documentation must be continuously invested in order to comply with regulations such as the FDA's Quality Systems Regulation (QSR), the Medical Device Regulation (MDR) in Europe, and numerous international standards for radiation safety. Additionally, updates to current radiation dose management solutions may be required due to changes in regulatory frameworks or the introduction of new mandates, which would result in longer implementation periods and higher costs.
Radiation dose management has been greatly impacted by the COVID-19 pandemic, which has brought about both opportunities and challenges. Although the pandemic's early stages caused disruptions to healthcare services, such as a drop in the volume of diagnostic imaging tests and elective procedures, the importance of radiation dose optimization has been highlighted by the subsequent focus on infection control and patient safety. Furthermore, dose management solutions have been given top priority by healthcare facilities in an effort to reduce radiation exposure to patients without sacrificing treatment effectiveness or diagnostic accuracy.
The Computed Tomography segment is expected to be the largest during the forecast period
The radiation dose management market is expected to be dominated by the computed tomography (CT) segment. Due to the widespread use of CT imaging in many different medical specialties for treatment guidance, surgical planning, and diagnostics, there is an increased need for radiation dose management techniques. Moreover, healthcare providers must prioritize dose optimization for CT scans because they require higher radiation doses than other imaging modalities. As a result, radiation dose management strategies designed especially for CT imaging have become increasingly popular.
The Cloud-Based segment is expected to have the highest CAGR during the forecast period
In the radiation dose management market, the cloud-based segment usually has the highest CAGR. The scalability, flexibility, and accessibility of cloud-based radiation dose management solutions enable healthcare providers to safely store, process, and evaluate radiation dose data on the cloud. Efficiency and cost-effectiveness are increased by these solutions abilities to monitor data in real-time, provide remote access to dose analytics, and integrate seamlessly with the current healthcare IT infrastructure. Additionally, the need for cloud-based radiation dose management solutions is fuelled by the expanding use of cloud-based technologies in healthcare as well as the growing emphasis on data interoperability and analytics-driven decision-making.
When it comes to the radiation dose management market, North America usually has the largest share. Numerous factors contribute to the region's dominance, such as the existence of a strong healthcare infrastructure, high rates of adoption of cutting-edge medical imaging technologies, strict regulations that prioritize radiation safety, and large investments in healthcare IT solutions. Furthermore, the need for radiation dose management solutions is also driven in North America by healthcare providers' proactive approach to technology adoption and their strong emphasis on patient safety.
The radiation dose management market usually shows the highest CAGR in the Asia-Pacific area. Increased healthcare spending, the quick uptake of cutting-edge medical imaging technologies, growing concern over radiation safety, and the development of expanding healthcare infrastructure in nations like China, India, Japan, and South Korea are some of the factors driving this growth. Moreover, the need for radiation dose management solutions in the area is also driven by government initiatives to modernize healthcare systems, increase access to high-quality healthcare services, and put in place regulatory frameworks to guarantee patient safety.
Key players in the market
Some of the key players in Radiation Dose Management market include GE Healthcare, Canon Inc., Medic Vision, Agfa Healthcare, FUJIFILM Holdings Corporation, Novarad Corporation, Siemens Healthcare, Infinitt Healthcare Co. Ltd., Bayer AG, Mirion Technologies, Inc., Philips Healthcare, Sectra AB, Volpara Helath Limited, Qaelum N.V. and Bracco Imaging S.P.A.
In March 2024, Medic Vision Imaging Solutions has inked a distribution contract for its AI-driven MRI image enhancement software with a Mumbai, India-based company. Equipment supplier Akarui Solutions will distribute Medic Vision's iQMR software, which speeds MRI scans by 40%, according to the firm.
In January 2024, Canon Medical Systems Corporation and Olympus Corporation, announced that we have reached an agreement to collaborate on Endoscopic Ultrasound Systems. Canon Medical will develop and manufacture diagnostic ultrasound systems used in Endoscopic Ultrasonography1 (EUS), and Olympus will perform the sales and marketing efforts.
In December 2023, GE Healthcare has entered into a distribution agreement with mobile-first clinical surveillance technology provider, AirStrip to expand AirStrip Cardiology and Patient Monitoring solutions in the US. The mobile application from AirStrip enables clinicians to view clinical data on the web and on mobile devices. It connects with cardiac rhythm strips and 12-lead ECGs, allowing clinicians to monitor numerous patients at the same time and can receive STEMI notifications.